[breadcrumb_custom]

Twist Bioscience Corp (NASDAQ: TWST): This Is The Year For Success Over The Next Few Months

In the last trading session, 1.71 million Twist Bioscience Corp (NASDAQ:TWST) shares changed hands as the company’s beta touched 1.63. With the company’s per share price at $40.61 changed hands at $2.42 or 6.34% during last session, the market valuation stood at $2.35B. TWST’s last price was a premium, traded about 2.14% off its 52-week high of $39.74. The share price had its 52-week low at $11.46, which suggests the last value was 71.78% up since then. When we look at Twist Bioscience Corp’s average trading volume, we note the 10-day average is 1.19 million shares, with the 3-month average coming to 1.32.

Twist Bioscience Corp (NASDAQ:TWST) trade information

Instantly TWST was in green as seen at the end of in last trading. With action 11.54%, the performance over the past five days has been green. The jump to weekly highs of 40.83 added 6.34% to the stock’s daily price. The company’s shares are showing year-to-date upside of 10.17%, with the 5-day performance at 11.54% in the green. However, in the 30-day time frame, Twist Bioscience Corp (NASDAQ:TWST) is 13.31% up. Looking at the short shares, we see there were 12.33 million shares sold at short interest cover period of 12.09 days.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Twist Bioscience Corp (TWST) estimates and forecasts

Data shows that the Twist Bioscience Corp share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 82.03% over the past 6 months, a 12.43% in annual growth rate that is considerably lower than the industry average of 15.50%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2024 revenue estimates. The rating firms predict current quarter revenue for Twist Bioscience Corp will rise 22.10%, while the growth in revenue is estimated to hit 23.80% for the next quarter. Year-over-year growth is forecast to reach 19.60% up from the last financial year.

Consensus estimates given by 8 financial analysts project the company’s revenue in the current quarter to hit an average of $70.65 million. 8 analysts are of the opinion that Twist Bioscience Corp’s revenue for the quarter ending Jun 2024 will be $73.8 million.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -6.09%. The 2024 estimates are for Twist Bioscience Corp earnings to increase by 14.48%.

TWST Dividends

Twist Bioscience Corp is expected to release its next quarterly earnings report between May 03 and May 07.

Twist Bioscience Corp (NASDAQ:TWST)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 1.75% of Twist Bioscience Corp shares while 109.64% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 111.59%. There are 109.64% institutions holding the Twist Bioscience Corp stock share, with Blackrock Inc. the top institutional holder. As of Jun 29, 2023, the company held 12.03% of the shares, roughly 6.91 million TWST shares worth $141.28 million.

ARK Investment Management, LLC holds the second largest percentage of outstanding shares, with 11.82% or 6.79 million shares worth $137.48 million as of Sep 29, 2023.

Among Mutual Funds, the top two as of Aug 30, 2023 were SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and ARK ETF Tr-ARK Innovation ETF. With 3.49 million shares estimated at $76.77 million under it, the former controlled 6.08% of total outstanding shares. On the other hand, ARK ETF Tr-ARK Innovation ETF held about 6.06% of the shares, roughly 3.48 million shares worth around $70.48 million.

On Key

Related Posts